Mee@reddthat.com to News@lemmy.worldEnglish · edit-22 days agoThe US Approved an Alzheimer's Drug. Seven Patients Subsequently Died.nationalpost.comexternal-linkmessage-square5fedilinkarrow-up184arrow-down110file-text
arrow-up174arrow-down1external-linkThe US Approved an Alzheimer's Drug. Seven Patients Subsequently Died.nationalpost.comMee@reddthat.com to News@lemmy.worldEnglish · edit-22 days agomessage-square5fedilinkfile-text
Three others also suffered lasting disabilities, according to FDA reports obtained by a Freedom of Information Act request Bloomberg. The Boston Globe.
minus-squareJohnDClay@sh.itjust.workslinkfedilinkarrow-up38arrow-down2·2 days agoBecause of the drug? Causation is really important to establish here. If this is standard for proportion of people within the tested age group, then that’s fine. But if not, it needs to be communicated much better than this.
minus-squareHellsBelle@sh.itjust.workslinkfedilinkEnglisharrow-up8·edit-22 days ago She died last July after experiencing “severe” brain swelling and bleeding — known side effects of the drug — Aaron is one of at least seven people who have died in the US from symptoms linked to the drug Leqembi over the past two years, https://www.bostonglobe.com/2025/03/31/business/alzheimers-drug-leqembi-biogen-eisai-patient-deaths/
Because of the drug? Causation is really important to establish here. If this is standard for proportion of people within the tested age group, then that’s fine. But if not, it needs to be communicated much better than this.
https://www.bostonglobe.com/2025/03/31/business/alzheimers-drug-leqembi-biogen-eisai-patient-deaths/